GenePOC CDiff
C. Difficile Toxin Gene Amplification Assay. 510(k) K172569, from Genepoc, Inc. (Quebec, CA). Product code OZN, class 2.
As of Nov 20, 2026, K172569 is an FDA 510(k) held by Genepoc, Inc., substantially equivalent on Nov 22, 2017 after 89 days, with 1 recall tied to it in FDA's recall database.
- Review time: 89 days
- Recalls: 1
- Cited as a predicate by: 1 device
The GenePOC CDiff assay performed on the revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI).
- BD Max Cdiff Assay, BD Max InstrumentK130470 · Geneohm Sciences Canada, Inc. (Bd Diagnostics) · Apr 2, 2013
- Great Basin Toxigenic C. difficile Direct Test (CDF2)K232092 · Vela Operations USA · Nov 14, 2023
| Started | Recall | Status |
|---|---|---|
| Dec 5, 2025 | Z-1019-2026The affected lots show a decline in performance over time, which may lead to false-negative results. | Open |
- cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative…K260045 · Roche Molecular Systems, Inc. · Aug 28, 2026
- Xpert C. difficile/EpiK243730 · Cepheid® · Feb 28, 2025
- Great Basin Toxigenic C. difficile Direct Test (CDF2)K232092 · Vela Operations USA · Nov 14, 2023
- cobas Cdiff nucleic acid test for use on the cobas Liat SystemK212427 · Roche Molecular Systems, Inc. · Oct 20, 2021
- cobas Cdiff nucleic acid test for use on the cobas Liat SystemK210385 · Roche Molecular Systems, Inc. · Sep 9, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 25, 2017
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3130
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files